146 related articles for article (PubMed ID: 12811200)
1. COX-2 and angiogenesis in gastric cancer.
Walther Z
J Clin Gastroenterol; 2003 Jul; 37(1):4-6. PubMed ID: 12811200
[No Abstract] [Full Text] [Related]
2. Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer.
Joo YE; Rew JS; Seo YH; Choi SK; Kim YJ; Park CS; Kim SJ
J Clin Gastroenterol; 2003 Jul; 37(1):28-33. PubMed ID: 12811205
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
Yao M; Kargman S; Lam EC; Kelly CR; Zheng Y; Luk P; Kwong E; Evans JF; Wolfe MM
Cancer Res; 2003 Feb; 63(3):586-92. PubMed ID: 12566300
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2: a therapeutic target in angiogenesis.
Iñiguez MA; RodrÃguez A; Volpert OV; Fresno M; Redondo JM
Trends Mol Med; 2003 Feb; 9(2):73-8. PubMed ID: 12615041
[TBL] [Abstract][Full Text] [Related]
5. [Colon cancer and COX-2].
Ota S; Bamba H; Imai Y; Arai S; Fujiwara K
Nihon Shokakibyo Gakkai Zasshi; 2002 Mar; 99(3):253-63. PubMed ID: 11925862
[No Abstract] [Full Text] [Related]
6. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.
Gupta RA; Tejada LV; Tong BJ; Das SK; Morrow JD; Dey SK; DuBois RN
Cancer Res; 2003 Mar; 63(5):906-11. PubMed ID: 12615701
[TBL] [Abstract][Full Text] [Related]
7. Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer.
Yu HG; Li JY; Yang YN; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
Cancer Lett; 2003 May; 195(1):43-51. PubMed ID: 12767510
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
[TBL] [Abstract][Full Text] [Related]
10. Re: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
Gallo O
J Natl Cancer Inst; 2000 Feb; 92(4):346-7. PubMed ID: 10675387
[No Abstract] [Full Text] [Related]
11. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1.
Sales KJ; Katz AA; Howard B; Soeters RP; Millar RP; Jabbour HN
Cancer Res; 2002 Jan; 62(2):424-32. PubMed ID: 11809691
[TBL] [Abstract][Full Text] [Related]
12. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic implantation of a colon cancer xenograft induces high expression of cyclooxygenase-2.
Shoji T; Konno H; Tanaka T; Sakaguchi T; Sunayama K; Baba M; Kamiya K; Ohta M; Kaneko T; Igarashi A; Nakamura S
Cancer Lett; 2003 Jun; 195(2):235-41. PubMed ID: 12767532
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells.
Li G; Yang T; Yan J
Biochem Biophys Res Commun; 2002 Dec; 299(5):886-90. PubMed ID: 12470662
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
16. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.
Murono S; Inoue H; Tanabe T; Joab I; Yoshizaki T; Furukawa M; Pagano JS
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6905-10. PubMed ID: 11381123
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
Ghosh AK; Hirasawa N; Niki H; Ohuchi K
J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
[TBL] [Abstract][Full Text] [Related]
18. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes.
Kim MH; Seo SS; Song YS; Kang DH; Park IA; Kang SB; Lee HP
Gynecol Oncol; 2003 Jul; 90(1):83-90. PubMed ID: 12821346
[TBL] [Abstract][Full Text] [Related]
20. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells.
Eibl G; Bruemmer D; Okada Y; Duffy JP; Law RE; Reber HA; Hines OJ
Biochem Biophys Res Commun; 2003 Jul; 306(4):887-97. PubMed ID: 12821125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
